FDA grants orphan drug status to rofecoxib for hemophilic arthropathyNovember 22, 2017Business of Medicine
CMS to enlist Medicare Part D plans to combat opioid abuseNovember 21, 2017Business of MedicinePainOpioid Resource Center
VIDEO: Advanced alternative payment model for RA set to undergo testingNovember 20, 2017Rheumatoid ArthritisBusiness of Medicine
FDA addresses cell-based regenerative medicine in comprehensive new policyNovember 16, 2017Business of MedicineFDA Actions
Legislative landscape affecting rheumatology has potential wins but many challengesNovember 7, 2017Business of Medicine
White House opioid panel calls for more addiction specialistsNovember 5, 2017PainOpioid Resource CenterBusiness of Medicine
Docs to receive slightly better Medicare pay bump than originally proposedNovember 4, 2017Business of Medicine
